Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Kays123on Feb 25, 2018 10:43pm
272 Views
Post# 27618865

Great News: get ready to fly!!!

Great News: get ready to fly!!!
Vancouver, British Columbia – (February 22, 2018) THC BioMed Intl Ltd. (CSE: THC), 
("THC" or the "Company") announces that it has received Good Manufacturing Practice (“GMP”)
certification for the production of Marijuana Plants and dried Marijuana.
THC has been assessed and meets the requirements of GOOD MANUFACTURING PRACTICE 
under the Codex Alimentarius Commission, Recommended International Code of Practices, 
General Principles of Food Hygiene, CAC/RCP 1-1969, Rev. 4 (2003) for the production of 
Marijuana Plants, dried Marijuana (Propagation, Growing, Harvesting, Drying, Curing and 
Packaging).
“This certification is significant. It recognizes our high standards and now paves the way for 
THC BioMed International to export its products into international markets. We are excited to 
begin the process of exporting our products to Europe and other markets,” said John Miller, 
President and CEO of THC, “We have begun the process of strengthening our international 
presence. The international cannabis market displays strong signs of growth and signals 
indicate a strong demand for high-grade cannabis products internationally.”
“Our expansion in anticipation of the recreational cannabis market is on target and we expect to 
introduce an additional 10 cannabis production rooms within the next few weeks,” said Mr. 
Miller
Bullboard Posts